Epigenetics of Neuromuscular Disorders

References

• Deenen JC , HorlingsCG , VerschuurenJJ , VerbeekAL , van EngelenBG. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J. Neuromuscul. Dis.2(1), 73–85 (2015).
   PubMedGoogle Scholar
• Iolascon G , PaolettaM , LiguoriS , CurciC , MorettiA. Neuromuscular diseases and bone. Front. Endocrinol. (Lausanne)10, 794 (2019).
   PubMed Web of Science ®Google Scholar
• Bennett SA , TanazR , CobosSN , TorrenteMP. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Transl. Res.204, 19–30 (2019).
   PubMed Web of Science ®Google Scholar
• Cerrato F , SparagoA , ArianiFet al. DNA methylation in the diagnosis of monogenic diseases. Genes (Basel)11(4), e355 (2020).
   PubMed Web of Science ®Google Scholar
• Kariyawasam DST , D’SilvaA , LinC , RyanMM , FarrarMA. Biomarkers and the development of a personalized medicine approach in spinal muscular atrophy. Front. Neurol.10, 898 (2019).
   PubMed Web of Science ®Google Scholar
• Mroczek M , MachońL , FilipczyńskaI. Molecular biomarkers for neuromuscular disorders–challenges and future perspectives. Neurol. Neurochir. Pol.53(3), 173–180 (2019).
   PubMed Web of Science ®Google Scholar
• Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet.13, 484–492 (2012).
   PubMed Web of Science ®Google Scholar
• Goll MG , BestorTH. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem.74, 481–514 (2005).
   PubMed Web of Science ®Google Scholar
• Bannister AJ , KouzaridesT. Regulation of chromatin by histone modifications. Cell Res.21(3), 381–395 (2011).
   PubMed Web of Science ®Google Scholar
• Berger SL . The complex language of chromatin regulation during transcription. Nature447, 407–412 (2007).
   PubMed Web of Science ®Google Scholar
• Cremer T , CremerC. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet.2(4), 292–301 (2001).
   PubMed Web of Science ®Google Scholar
• Andrey G , MundlosS. The three-dimensional genome: regulating gene expression during pluripotency and development. Development144, 3646–3658 (2017).
   PubMed Web of Science ®Google Scholar
• Sun JH , ZhouL , EmersonDJet al. Disease-associated short tandem repeats co-localize with chromatin domain boundaries. Cell175(1), 224–238.e15 (2018).
   PubMed Web of Science ®Google Scholar
• Dumbovic G , ForcalesSV , PeruchoM. Emerging roles of macrosatellite repeats in genome organization and disease development. Epigenetics12(7), 515–526 (2017).
   PubMed Web of Science ®Google Scholar
• Stoccoro A , CoppedèF. Role of epigenetics in Alzheimer’s disease pathogenesis. Neurodegener. Dis. Manag.8(3), 181–193 (2018).
   PubMed Web of Science ®Google Scholar
• Wilczynska A , BushellM. The complexity of miRNA-mediated repression. Cell Death Differ.22(1), 22–33 (2015).
   PubMed Web of Science ®Google Scholar
• Grad LI , RouleauGA , RavitsJ , CashmanNR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb. Perspect. Med.7(8), a024117 (2017).
   PubMed Web of Science ®Google Scholar
• Kolb SJ , KisselJT. Spinal muscular atrophy. Neurol. Clin.33(4), 831–846 (2015).
   PubMed Web of Science ®Google Scholar
• Figueroa-Romero C , HurJ , BenderDEet al. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS ONE7, e52672 (2012).
   PubMed Web of Science ®Google Scholar
• Tremolizzo L , MessinaP , ContiEet al. Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotroph. Lateral Scler. Front. Degener.15, 98–105 (2014).
   PubMed Web of Science ®Google Scholar
• Hamzeiy H , SavaşD , Tuncaet al. Elevated global DNA methylation is not exclusive to amyotrophic lateral sclerosis and is also observed in spinocerebellar ataxia types 1 and 2. Neurodegener. Dis.18(1), 38–48 (2018).
   PubMed Web of Science ®Google Scholar
• Coppedè F , StoccoroA , MoscaLet al. Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations. Amyotroph. Lateral Scler. Frontotemporal Degener.19(1-2), 93–101 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang M , XiZ , GhaniMet al. Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28. J. Neurol. Neurosurg. Psychiatry87(11), 1268–1270 (2016).
   PubMed Web of Science ®Google Scholar
• Young PE , KumJew S , BucklandME , PamphlettR , SuterCM. Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis. PLoS One12(8), e0182638 (2017).
   PubMed Web of Science ®Google Scholar
• Tarr IS , McCannEP , BenyaminBet al. Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression. Sci. Rep.9(1), 8254 (2019).
   PubMedGoogle Scholar
• Wong M , GertzB , ChestnutBA , MartinLJ. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front. Cell. Neurosci.7, 279 (2013).
   PubMed Web of Science ®Google Scholar
• Stoccoro A , MoscaL , CarnicelliVet al. Mitochondrial DNA copy number and D-loop region methylation in carriers of amyotrophic lateral sclerosis gene mutations. Epigenomics10(11), 1431–1443 (2018).
   PubMed Web of Science ®Google Scholar
• Xi Z , ZinmanL , MorenoDet al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am. J. Hum. Genet.92(6), 981–989 (2013).
   PubMed Web of Science ®Google Scholar
• Belzil VV , BauerPO , GendronTF , MurrayME , DicksonD , PetrucelliL. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res.1584, 15–21. (2014).
   PubMed Web of Science ®Google Scholar
• Gijselinck I , Van MosseveldeS , vander Zee Jet al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol. Psychiatry21(8), 1112–1124 (2016).
   PubMed Web of Science ®Google Scholar
• JM, Yu B , TrentRJ , PamphlettR. A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler.10(5-6), 418–429 (2009).
   PubMedGoogle Scholar
• Lam L , ChinL , HalderRCet al. Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients. FASEB J.30(10), 3461–3473 (2016).
   PubMed Web of Science ®Google Scholar
• Rouaux C , JokicN , MbebiC , BoutillierS , LoefflerJP , BoutillierAL. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J.22(24), 6537–6549 (2003).
   PubMed Web of Science ®Google Scholar
• Pigna E , SimonazziE , SannaKet al. Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine40, 717–732 (2019).
   PubMed Web of Science ®Google Scholar
• Dios AM , BabuS , GranucciEJet al. Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: neuropathological and positron emission tomography molecular neuroimaging evidence. Muscle Nerve60(4), 443–452 (2019).
   PubMed Web of Science ®Google Scholar
• Sugai F , YamamotoY , MiyaguchiKet al. Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur. J. Neurosci.20(11), 3179–3183 (2004).
   PubMed Web of Science ®Google Scholar
• Ryu H , SmithK , CameloSIet al. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J. Neurochem.93(5), 1087–1098 (2005).
   PubMed Web of Science ®Google Scholar
• Yoo YE , KoCP. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol.231(1), 147–59 (2011).
   PubMed Web of Science ®Google Scholar
• Rossaert E , PollariE , JaspersTet al. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol. Commun.7(1), 107 (2019).
   PubMedGoogle Scholar
• Kuta R , LarochelleN , FernandezMet al. Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models. Cell Stress Chaperones25(1), 173–191 (2020).
   PubMed Web of Science ®Google Scholar
• Boutillier AL , TzeplaeffL , DupuisL. The dark side of HDAC inhibition in ALS. EBioMedicine41, 38–39 (2019).
   PubMed Web of Science ®Google Scholar
• Foggin S , Mesquita-RibeiroR , Dajas-BailadorF , LayfieldR. Biological significance of microRNA biomarkers in ALS–innocent bystanders or disease culprits?Front. Neurol.10, 578 (2019).
   PubMed Web of Science ®Google Scholar
• Joilin G , LeighPN , NewburySF , HafezparastM. An overview of microRNAs as biomarkers of ALS. Front. Neurol.10, 186 (2019).
   PubMed Web of Science ®Google Scholar
• Wang L , ZhangL. Circulating microRNAs as diagnostic biomarkers for motor neuron disease. Front. Neurosci.14, 354 (2020).
   PubMed Web of Science ®Google Scholar
• Hauke J , RiesslandM , LunkeSet al. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum. Mol. Genet.18, 304–317 (2009).
   PubMed Web of Science ®Google Scholar
• Cao YY , QuYJ , HeSXet al. Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophy. J. Zhejiang Univ. Sci. B.17, 76–82 (2016).
   PubMed Web of Science ®Google Scholar
• Zheleznyakova GY , VoisinS , KiselevAVet al. Genome-wide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity. Eur. J. Hum. Genet.21, 988–993 (2013).
   PubMed Web of Science ®Google Scholar
• Zheleznyakova GY , NilssonEK , KiselevAVet al. Methylation levels of SLC23A2 and NCOR2 genes correlate with spinal muscular atrophy severity. PLoS One10, e0121964 (2015).
   PubMed Web of Science ®Google Scholar
• Maretina M , EgorovaA , BaranovV , KiselevA. DYNC1H1 gene methylation correlates with severity of spinal muscular atrophy. Ann. Hum. Genet.83, 73–81 (2019).
   PubMed Web of Science ®Google Scholar
• Mohseni J , Zabidi-HussinZA , SasongkoTH. Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy. Genet. Mol. Biol.36, 299–307 (2013).
   PubMed Web of Science ®Google Scholar
• Brahe C , VitaliT , TizianoFDet al. Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. Eur. J. Hum. Genet.13, 256–259 (2005).
   PubMed Web of Science ®Google Scholar
• Piepers S , CobbenJM , SodaarPet al. Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid. J. Neurol. Neurosurg. Psychiatry82, 850–852 (2010).
   PubMed Web of Science ®Google Scholar
• Magri F , VanoliF , CortiS. MiRNA in spinal muscular atrophy pathogenesis and therapy. J. Cell. Mol. Med.22, 755–767 (2018).
   PubMed Web of Science ®Google Scholar
• Bonanno S , MarcuzzoS , MalacarneCet al. Circulating myomiRs as potential biomarkers to monitor response to nusinersen in pediatric SMA patients. Biomedicines8, 21 (2020).
   PubMed Web of Science ®Google Scholar
• Singh RN , SeoJ , SinghNN. RNA in spinal muscular atrophy: therapeutic implications of targeting. Expert Opin. Ther. Targets24(8), 731–743 (2020).
   PubMed Web of Science ®Google Scholar
• Ottesen EW . ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy. Transl. Neurosci.8, 1–6 (2017).
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A , HardimanO , KiernanMC , Chio'A , Rix-BrooksB , vanden Berg LH. Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol.15, 1182–1194 (2016).
   PubMed Web of Science ®Google Scholar
• Ji AL , ZhangX , ChenWW , HuangWJ. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. J. Med. Genet.54, 145–154 (2017).
   PubMed Web of Science ®Google Scholar
• van Rheenen W , ShatunovA , DekkerAMet al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet.48, 1043–1048 (2016).
   PubMed Web of Science ®Google Scholar
• Balendra R , IsaacsAM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol.14(9), 544–558 (2018).
   PubMed Web of Science ®Google Scholar
• Nabais MF , LinT , BenyaminBet al. Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis. NPJ Genom. Med.5, 10 (2020).
   PubMed Web of Science ®Google Scholar
• Chestnut BA , ChangQ , PriceA , LesuisseC , WongM , MartinLJ. Epigenetic regulation of motor neuron cell death through DNA methylation. J. Neurosci.31(46), 16619–16636 (2011).
   PubMed Web of Science ®Google Scholar
• Oates N , PamphlettR. An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph. Lateral Scler.8(2), 83–86 (2007).
   PubMed Web of Science ®Google Scholar
• Morahan JM , YuB , TrentRJ , PamphlettR. Are metallothionein genes silenced in ALS?Toxicol. Lett.168(1), 83–87 (2007).
   PubMed Web of Science ®Google Scholar
• Yang Y , GozenO , VidenskyS , RobinsonMB , RothsteinJD. Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. Glia58(3), 277–286 (2010).
   PubMed Web of Science ®Google Scholar
• Xi Z , ZhangM , BruniACet al. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol.129, 715–727 (2015).
   PubMed Web of Science ®Google Scholar
• Ng ASL , TanEK. Intermediate C9orf72 alleles in neurological disorders: does size really matter?J. Med. Genet.54(9), 591–597 (2017).
   PubMed Web of Science ®Google Scholar
• Coppedè F . The potential of epigenetic therapies in neurodegenerative diseases. Front. Genet.5, 220 (2014).
   PubMed Web of Science ®Google Scholar
• Zhang YJ , GuoL , GonzalesPKet al. Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science363, 6428 (2019).
   Web of Science ®Google Scholar
• Maretina MA , ZheleznyakovaGY , LankoKM , EgorovaAA , BaranovVS , KiselevAV. Molecular factors involved in spinal muscular atrophy pathways as possible disease-modifying candidates. Curr. Genomics19, 339–355 (2018).
   PubMed Web of Science ®Google Scholar
• Harms MB , Ori-McKenneyKM , ScotoMet al. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology78, 1714–1720 (2012).
   PubMed Web of Science ®Google Scholar
• Tsurusaki Y , SaitohS , TomizawaKet al. A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics13, 327–332 (2012).
   PubMed Web of Science ®Google Scholar
• Mohseni J , Al-NajjarBO , WahabHA , Zabidi-HussinZA , SasongkoTH. Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and dacinostat, on SMN2 expression in fibroblasts of SMA patients. J. Hum. Genet.61, 823–830 (2016).
   PubMed Web of Science ®Google Scholar
• Lai JI , LemanLJ , KuSet al. Cyclic tetrapeptide HDAC inhibitors as potential therapeutics for spinal muscular atrophy: screening with iPSC-derived neuronal cells. Bioorg. Med. Chem. Lett.27, 3289–3293 (2017).
   PubMed Web of Science ®Google Scholar
• Ottesen EW , SinghRN. Characteristics of circular RNAs generated by human survival motor neuron genes. Cell. Signal.73, 109696 (2020).
   PubMed Web of Science ®Google Scholar
• Brusa R , MagriF , BresolinN , ComiGP , CortiS. Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives. Cell. Mol. Life Sci. doi:10.1007/s00018-020-03537-4 (2020) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Zaharieva IT , CalissanoM , ScotoMet al. Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular dystrophy. PLoS ONE8, e80263 (2013).
   PubMed Web of Science ®Google Scholar
• Becker S , FlorianA , PatrascuAet al. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach. J. Cardiovasc. Magn. Reson.18, 25 (2016).
   PubMed Web of Science ®Google Scholar
• Trifunov S , Natera-deBenito D , ExpositoEscudero JMet al. Longitudinal study of three microRNAs in Duchenne muscular dystrophy and Becker muscular dystrophy. Front. Neurol.11, 304 (2020).
   PubMed Web of Science ®Google Scholar
• Cacchiarelli D , IncittiT , MartoneJet al. MiR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep.12, 136–141 (2012).
   Web of Science ®Google Scholar
• Greco S , CardinaliB , FalconeG , MartelliF. Circular RNAs in muscle function and disease. Int. J. Mol. Sci.19, 3454 (2018).
   PubMed Web of Science ®Google Scholar
• Legnini I , DiTimoteo G , RossiFet al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol. Cell.66, 22–37 (2017).
   PubMed Web of Science ®Google Scholar
• Barbé L , LanniS , López-CastelAet al. CpG methylation, a parent-of-origin effect for maternal-biased transmission of congenital myotonic dystrophy. Am. J. Hum. Genet.100, 488–505 (2017).
   PubMed Web of Science ®Google Scholar
• Steinbach P , GläserD , VogelW , WolfM , SchwemmleS. The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am. J. Hum. Genet.62, 278–285 (1998).
   PubMed Web of Science ®Google Scholar
• Nakamori M , HamanakaK , ThomasJDet al. Aberrant myokine signaling in congenital myotonic dystrophy. Cell. Rep.21, 1240–1252 (2017).
   PubMed Web of Science ®Google Scholar
• Rizzo M , BeffyP , DelCarratore Ret al. Activation of the interferon type I response rather than autophagy contributes to myogenesis inhibition in congenital DM1 myoblasts. Cell Death Dis.9, 1071 (2018).
   PubMed Web of Science ®Google Scholar
• Santoro M , FontanaL , MasciulloMet al. Expansion size and presence of CCG/CTC/CGG sequence interruptions in the expanded CTG array are independently associated to hypermethylation at the DMPK locus in myotonic dystrophy type 1 (DM1). Biochim. Biophys. Acta1852, 2645–2652 (2015).
   PubMed Web of Science ®Google Scholar
• Légaré C , OverendG , GuaySPet al. DMPK gene DNA methylation levels are associated with muscular and respiratory profiles in DM1. Neurol. Genet.5, e338 (2019).
   PubMed Web of Science ®Google Scholar
• Pegoraro V , CudiaP , BabaA , AngeliniC. MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy. Neurol. Sci.41(10), 2953–2960 (2020).
   PubMed Web of Science ®Google Scholar
• López Castel A , OverbySJ , ArteroR. MicroRNA-based therapeutic perspectives in myotonic dystrophy. Int. J. Mol. Sci.20, 5600 (2019).
   PubMed Web of Science ®Google Scholar
• Cerro-Herreros E , Sabater-ArcisM , Fernandez-CostaJMet al. MiR-23b and miR-218 silencing increase muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models. Nat. Commun.9, 2482 (2018).
   PubMed Web of Science ®Google Scholar
• Voellenkle C , PerfettiA , CarraraMet al. Dysregulation of circular RNAs in myotonic dystrophy type 1. Int. J. Mol. Sci.20, 1938 (2019).
   PubMed Web of Science ®Google Scholar
• Czubak K , TaylorK , PiaseckaAet al. Global increase in circular RNA levels in myotonic dystrophy. Front. Genet.10, 649 (2019).
   PubMed Web of Science ®Google Scholar
• Hartweck LM , AndersonLJ , LemmersRJet al. A focal domain of extreme demethylation within D4Z4 in FSHD2. Neurology80(4), 392–399 (2013).
   PubMed Web of Science ®Google Scholar
• Jones TI , YanC , SappPCet al. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing. Clin. Epigenet.6, 23 (2014).
   PubMed Web of Science ®Google Scholar
• Gaillard MC , RocheS , DionCet al. Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers. Neurology83(8), 733–742 (2014).
   PubMed Web of Science ®Google Scholar
• Lemmers RJ , GoemanJJ , vander Vliet PJet al. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Hum. Mol. Genet.24(3), 659–669 (2015).
   PubMed Web of Science ®Google Scholar
• Ottaviani A , Schluth-BolardC , Rival-GervierSet al. Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF. EMBO J.28(16), 2428–2436 (2009).
   PubMed Web of Science ®Google Scholar
• Ottaviani A , Schluth-BolardC , GilsonE , MagdinierF. D4Z4 as a prototype of CTCF and lamins-dependent insulator in human cells. Nucleus1(1), 30–36 (2010).
   PubMed Web of Science ®Google Scholar
• Robin JD , LudlowAT , BattenKet al. SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy. Genome Res.25(12), 1781–1790 (2015).
   PubMed Web of Science ®Google Scholar
• Bodega B , RamirezGD , GrasserFet al. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol.7, 41 (2009).
   PubMed Web of Science ®Google Scholar
• Pirozhkova I , PetrovA , DmitrievP , LaoudjD , LipinskiM , VassetzkyY. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy. PLoS One3(10), e3389 (2008).
   PubMed Web of Science ®Google Scholar
• Petrov A , PirozhkovaI , CarnacG , LaoudjD , LipinskiM , VassetzkyYS. Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc. Natl Acad. Sci. U. S. A.103(18), 6982–6987 (2006).
   PubMed Web of Science ®Google Scholar
• Gaillard MC , BroucqsaultN , MorereJet al. Analysis of the 4q35 chromatin organization reveals distinct long-range interactions in patients affected with facio-scapulo-humeral dystrophy. Sci. Rep.9(1), 10327 (2019).
   PubMedGoogle Scholar
• Cortesi A , PesantM , SinhaSet al. 4q-D4Z4 chromatin architecture regulates the transcription of muscle atrophic genes in facioscapulohumeral muscular dystrophy. Genome Res.29(6), 883–895 (2019).
   PubMed Web of Science ®Google Scholar
• Lim JW , WongCJ , YaoZet al. Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures. Hum. Mol. Genet.27, 2644–2657 (2018).
   PubMedGoogle Scholar
• Portilho DM , AlvesMR , KratassioukGet al. MiRNA expression in control and FSHD fetal human muscle biopsies. PLoS ONE10, e0116853 (2015).
   PubMed Web of Science ®Google Scholar
• Datta N , GhoshPS. Update on muscular dystrophies with focus on novel treatments and biomarkers. Curr. Neurol. Neurosci. Rep.20, 14 (2020).
   PubMed Web of Science ®Google Scholar
• Yoshioka M , YorifujiT , MituyoshiI. Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy. Clin. Genet.53, 102–107 (1998).
   PubMed Web of Science ®Google Scholar
• Richards CS , WatkinsSC , HoffmanEPet al. Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy. Am. J. Hum. Genet.46, 672–681 (1990).
   PubMed Web of Science ®Google Scholar
• Hrach HC , MangoneM. MiRNA profiling for early detection and treatment of Duchenne muscular dystrophy. Int. J. Mol. Sci.20, 4638 (2019).
   PubMed Web of Science ®Google Scholar
• Johnson NE . Myotonic muscular dystrophies. Continuum (Minneap. Minn.)25, 1682–1695 (2019).
   PubMedGoogle Scholar
• Lanni S , PearsonCE. Molecular genetics of congenital myotonic dystrophy. Neurobiol. Dis.132, 104533 (2019).
   PubMed Web of Science ®Google Scholar
• Otten AD , TapscottSJ. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl Acad. Sci. U.S.A.92, 5465–5469 (1995).
   PubMed Web of Science ®Google Scholar
• Castel AL , NakamoriM , ToméSet al. Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues. Hum. Mol. Genet.20, 1–15 (2011).
   PubMed Web of Science ®Google Scholar
• Brouwer JR , HuguetA , NicoleA , MunnichA , GourdonG. Transcriptionally repressive chromatin remodelling and CpG methylation in the presence of expanded CTG-repeats at the DM1 locus. J. Nucleic Acids2013, 567435 (2013).
   PubMedGoogle Scholar
• Koutsoulidou A , KyriakidesTC , PapadimasGKet al. Elevated muscle-specific miRNAs in serum of myotonic dystrophy patients relate to muscle disease progress. PLoS One10, e0125341.2015 (2015).
   Web of Science ®Google Scholar
• Sabater-Arcis M , BargielaA , FurlingD , ArteroR. MiR-7 restores phenotypes in myotonic dystrophy muscle cells by repressing hyperactivated autophagy. Mol. Ther. Nucleic Acids19, 278–292 (2020).
   PubMedGoogle Scholar
• Greco A , GoossensR , van EngelenB , vander Maarel SM. Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy. Clin. Genet.97, 799–814 (2020).
   PubMed Web of Science ®Google Scholar
• Himeda CL , JonesPL. The genetics and epigenetics of facioscapulohumeral muscular dystrophy. Annu. Rev. Genomics Hum. Genet.20, 265–291 (2019).
   PubMed Web of Science ®Google Scholar
• Preston MK , TawilR , WangLH. Facioscapulohumeral muscular dystrophy. In: AdamMP, ArdingerHH, PagonRAet al.et al. ( Eds). GeneReviews^®WA, USAUniversity of Washington, Seattle; 1993–2020. 1999 Mar 8 ( updated2020 Feb 6).
   Google Scholar
• Himeda CL , JonesTI , VirbasiusCM , ZhuLJ , GreenMR , JonesPL. Identification of epigenetic regulators of DUX4-fl for targeted therapy of facioscapulohumeral muscular dystrophy. Mol. Ther.26, 1797–807 (2018).
   PubMed Web of Science ®Google Scholar
• Himeda CL , JonesTI , JonesPL. CRISPR/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy. Mol. Ther.24, 527–535 (2016).
   PubMed Web of Science ®Google Scholar
• Fang TK , YanCJ , DuJ. TLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines. Medicine (Baltimore)97, e0620 (2018).
   PubMed Web of Science ®Google Scholar
• Coppedè F , StoccoroA , NicolìVet al. Investigation of GHSR methylation levels in thymomas from patients with myasthenia gravis. Gene752, 144774 (2020).
   PubMed Web of Science ®Google Scholar
• Serfecz J , BazickH , AlSalihi MOet al. Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot-Marie-Tooth disease. Gene Ther.26, 455–464 (2019).
   PubMed Web of Science ®Google Scholar
• de Anda-Jáuregui G , McGregorBA , GuoK , HurJ. A network pharmacology approach for the identification of common mechanisms of drug-induced peripheral neuropathy. CPT Pharmacometrics Syst. Pharmacol.8, 211–219 (2019).
   PubMedGoogle Scholar
• Zhang HH , HanX , WangMet al. The association between genomic DNA methylation and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. J. Diabetes Res.2019, 2494057 (2019).
   PubMed Web of Science ®Google Scholar
• Guo K , ElzingaS , EidSet al. Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus. Epigenetics14, 766–779 (2019).
   PubMed Web of Science ®Google Scholar